Trial Profile
An Open-label, Single-dose, Pharmacokinetic Study of SENS-218 in Healthy Adult, Caucasian Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs SENS 218 (Primary)
- Indications Ear disorders
- Focus Pharmacokinetics
- 07 Sep 2016 Results published in the Media Release
- 25 Aug 2015 New trial record